• Epigenetic Immune Signatures in Melanoma

  2026-09-03

  Anichini et al. compared multiple epigenetic drug classes in melanoma and showed that guadecitabine produced the strongest and most consistent immune-related transcriptional program. The study links this DNMT inhibitor signature to innate immune regulators, patient biopsy responses, and improved prognostic associations, while also defining why epigenetic agents should not be treated as interchangeable immunotherapy partners.

• Caspase-4 Colorimetric Assay Kit Workflow

  2026-09-03

  Build a quantitative LEVD-dependent caspase-4 workflow for pyroptosis, inflammasome, and inflammatory signaling studies. This guide also shows how the assay can complement ER-targeted peptide self-assembly research without confusing caspase activity with proof of a specific cell-death mechanism.

• Oseltamivir acid: Applied Research Workflows

  2026-09-02

  Oseltamivir acid supports mechanism-led influenza antiviral research, resistance testing, and exploratory oncology studies. This guide translates its neuraminidase biology into practical assay workflows, human-relevant exposure questions, and troubleshooting strategies.

• Rencofilstat–Ixazomib in Advanced Prostate Cancer

  2026-09-02

  A 2025 Biomedicines study shows that combining the pan-cyclophilin inhibitor rencofilstat with the proteasome inhibitor ixazomib intensifies proteotoxic stress and apoptotic death in advanced prostate cancer cells while sparing non-cancer cells. Its mechanistic contribution is the identification of altered XBP1s, PERK, cyclophilin, CD147, and ERK signaling as interconnected determinants of treatment response.

• Fenipentol: From Natural Product to Assay Design

  2026-09-01

  Fenipentol, also known as 1-Phenyl-1-pentanol, connects a Ligusticum chuanxiong natural-product signal with testable gastrointestinal, hepatobiliary, and cardiovascular hypotheses. This article focuses on evidence hierarchy, assay selection, and practical workflow decisions rather than repeating a conventional mechanism overview.

• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody

  2026-09-01

  A scenario-driven guide to using HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1214, in immunofluorescence, flow cytometry, Western blotting, and tissue staining workflows. It explains how to improve detection of goat primary antibodies while separating fluorescence-based mechanistic readouts from direct cell-viability measurements.

• Persistent rDNA Damage and PML-Nucleolar Compartments

  2026-08-31

  Urbancokova, Hornofova and colleagues identify persistent ribosomal DNA damage as a specific trigger of PML-nucleolar associations, linking topological stress, RNA polymerase I inhibition, and incomplete homologous recombination. The study provides a useful framework for distinguishing transient genotoxic stress from lesions that reorganize nucleolar architecture and promote senescence.

• HRP Secondary Antibodies in Plastic Toxicology

  2026-08-31

  A translational perspective on how HRP-based immunodetection can strengthen mechanistic studies of microplastic- and nanoplastic-induced pulmonary fibrosis, with practical guidance for deploying goat primary antibodies across toxicology workflows.

• Microplastics, Nanoplastics, and Pulmonary Fibrosis

  2026-08-30

  A comparative study shows that polystyrene, polyethylene, and polypropylene microplastics and nanoplastics can promote fibrotic lung injury, with smaller particles and polystyrene producing the strongest effects. Its combined animal, epithelial-cell, and pathway-intervention design implicates dysregulated FXR–YAP1 signaling as a potential mechanism while highlighting important limits for translating exposure models to human risk.

• rTMS Activates GABAergic Cx3cl1-Cx3cr1 Signaling in AD

  2026-08-29

  This 2025 Cell Proliferation study links repetitive transcranial magnetic stimulation (rTMS) to cognitive recovery in 5xFAD mice through activation of GABAergic neurons and enhancement of the Cx3cl1-Cx3cr1 signaling axis. Single-cell transcriptomics and cellular analyses suggest that this pathway improves microglial phagocytosis, reduces amyloid plaque burden, and suppresses neuroinflammatory features.

• Dihydroartemisinin: Applied Research Workflows

  2026-08-28

  Build reproducible malaria, mTOR, and inflammation assays around a defined Dihydroartemisinin workflow rather than an undefined botanical preparation. This guide covers solvent handling, exposure design, reference-informed antiplasmodial assay choices, and troubleshooting for precipitation, light sensitivity, and pathway-level interpretation.

• Thrombin B Chain Fragment: Mechanism & Assays

  2026-08-28

  Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] is a defined 19-residue peptide fragment associated with the human F2 thrombin system. This article separates thrombin biology from the product’s fragment identity, summarizes assay-relevant specifications, and defines practical limits for coagulation and vascular research.

• CX-5461 in Cervical Cancer: Mitotic Catastrophe

  2026-08-27

  A 2026 Biochemical Pharmacology study shows that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by coupling DNA damage to abnormal mitotic entry and mitotic catastrophe. The study also reports enhanced cisplatin sensitivity, providing a mechanistic rationale for investigating Pol I inhibition in treatment-resistant cervical cancer models.

• DSS Models and the GPR35–KLF5 Repair Axis

  2026-08-27

  Dextran sulfate sodium salt (MW 35000-45000) is more than a routine colitis reagent: it is a controlled way to interrogate how epithelial injury becomes a repair decision. This thought-leadership guide connects DSS-based intestinal inflammation models with recent evidence on GPR35–KLF5 signaling, then translates that biology into practical study-design and translational strategy.

• Plk1 Control of p31comet in Checkpoint Disassembly

  2026-08-26

  This study identifies Polo-like kinase 1 (Plk1)-dependent phosphorylation of p31comet at S102 as a brake on mitotic checkpoint complex disassembly. The work links a specific post-translational modification to control of the p31comet–TRIP13 pathway, explaining how cells may prevent premature checkpoint silencing during chromosome alignment.

8500 records 1/567 page Next 12345 下5页 Last page